Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Darrell S. Rigel MD MS, one of the co-authors of A Randomized Controlled Trial Analyzing the Likeability, Usability,…
Read More
Curated by the JDD Editors Missed any of our June highlights? June is our Acne and Rosacea issue and is packed with intriguing articles, and you’ll want to start to…
Read More
Polymeric Cleansing Technologies and Tolerability in Sensitive Skin: A JDD Review to Note Have you read this article from the JDD? A recent review examines how modern skin cleansers have…
Read More
JDD Review: Botulinum Toxin A Shows Potential for Acne Vulgaris and Acne Scarring You don’t want to miss this article in the JDD. A systematic review in the Journal of…
Read More
Guest: Dr. Kamilia Smith From hormones and metabolism to mood and menopause, corticosteroids can influence far more than the condition they're prescribed to treat. In this installment of the JDD…
Read More
Beyond the Surface: Evolving Standards in Acne Management June marks Acne Awareness Month, serving as a critical pivot point to reframe acne vulgaris not as a temporary phase, but as…
Read More
New JDD Consensus Offers Practical Guidance on Cosibelimab for Advanced cSCC Have you read this article from the JDD A recent expert consensus addresses cosibelimab, a newly FDA approved PD-L1…
Read More
Discover a smarter way to meet your continuing medical education requirements DermEdge is a free CME platform from Forefront Dermatology and MedscapeLive! designed for todays busy dermatology professionals. This on-demand…
Read More
Physician’s Weekly interviewed dermatologist Geeta Yadav, MD, for her perspective on the March Journal of Drugs in Dermatology study, “Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.”…
Read More
Topical Metformin versus Kligman’s Formula for Melasma, a Split-Face JDD Study This is a must-read article from JDD a head-to-head split-face study asks whether topical metformin can be an effective,…
Read More
Extended Pembrolizumab Duration Tied to Lower Mortality in Stage III and IV Melanoma: JDD Report Could extending pembrolizumab improve survival? This JDD is a must read. A new retrospective analysis…
Read More
New JDD Study Introduces Objective Method for Measuring Periorbital Dynamic Lines For dermatology teams focused on antiaging care, this article from the JDD is a must read. Dermatologists and clinical…
Read More
